Rheumatology Advisor (9/16, Kuhns) reports, “Initiation of selective serotonin reuptake inhibitors (SSRI) among midlife women aged between 42 and 52 years is associated with a higher risk for fracture compared with nonusers…according to study results.” Meanwhile, the study found that “other antidepressants…were not linked to increased fracture risk.” The findings were published in the Journal of Bone and Mineral Research.
Related Links:
— “SSRI Use in Women Aged 42 to 52 Years Linked to Increased Fracture Risk,”Lisa Kuhns, Rheumatology Advisor, September 16, 2025